All < Article List

AstraZeneca’s Imfinzi becomes 1st immunotherapy approved in Korea for perioperative bladder cancer
Pharma Kim Ji-hye 08.04 14:13
Celltrion’s Yuflyma nears top spot in Europe with rapid market share gains
Bio Lee Han-soo 08.04 14:08
Urine acidity identified as predictor of bladder cancer recurrence: study
Hospital Lee Han-soo 08.04 13:44
Korean team 1st to explain how placental inflammation leads to allergies in children
Life science Song Soo-youn 08.04 13:40
Busan Medical Center reinvents itself to regain public trust and stay competitive
Hospital Kim Eun-young 08.04 13:23
HRD testing remains still not reimbursed for Korean ovarian cancer patients
Hospital Kim Yun-mi 08.04 11:05
Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva
Bio Kim Ji-hye 08.04 10:50
GC Labs’ pathology certification suspended after breast cancer surgery error from specimen mix-up
Life science Song Soo-youn 08.04 10:34
J&J’s Rybrevant-Lazcluze combo with Yuhan wins China approval, setting off $45 mil. milestone
Pharma Kim Ji-hye 08.01 18:27
Korean pharma scrambles to catch up on ESG as global standards tighten
Pharma Lee Han-soo 08.01 17:30
Amorepacific's Q2 profit jumps 555% as global sales surge, core brands rebound
K-Beauty Kim Ji-hye 08.01 16:58
Covid-19 cases expected to rise through August amid heatwave and vacation season: KDCA
Policy Kim Kyoung-Won 08.01 15:58
Reimbursement for oral Fabry disease drug Galafold expanded to 1st-line treatment
Pharma Park Gi-taek 08.01 15:49
Dental implants lead growth as Korea’s medical device market hits ₩10.5 trillion
Device/ICT Park Gi-taek 08.01 15:42
As Enhertu expands, AstraZeneca taps Korean startup AIVIS for AI-powered HER2 reads
Device/ICT Kim Ji-hye 08.01 15:32
[Column] Medical device approval: AI could be the answer – with a caveat
Opinion Lee Jin-hyu 08.01 15:09
From legacy brands to future breakthroughs: how Merck KGaA is redefining its role in oncology
Special Lee Han-soo 08.01 14:27
EzDiatech’s blood test for rapid concussion diagnosis lands Korean approval
Device/ICT Park Gi-taek 08.01 13:42
Konkuk’s blood toxicity-predicting AI wins grand prize at medical data contest
Hospital Song Soo-youn 08.01 13:31
Urinary urgency and pain during intercourse could signal interstitial cystitis
Hospital Lee Chang-ho 08.01 13:20

상단영역

본문영역

All articles 목록 ( 총 : 21,030 )

기사목록 보기 형태

AstraZeneca’s Imfinzi becomes 1st immunotherapy approved in Korea for perioperative bladder cancer

Celltrion’s Yuflyma nears top spot in Europe with rapid market share gains

Urine acidity identified as predictor of bladder cancer recurrence: study

Korean team 1st to explain how placental inflammation leads to allergies in children

Busan Medical Center reinvents itself to regain public trust and stay competitive

HRD testing remains still not reimbursed for Korean ovarian cancer patients

Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva

GC Labs’ pathology certification suspended after breast cancer surgery error from specimen mix-up

J&J’s Rybrevant-Lazcluze combo with Yuhan wins China approval, setting off $45 mil. milestone

Korean pharma scrambles to catch up on ESG as global standards tighten

Amorepacific's Q2 profit jumps 555% as global sales surge, core brands rebound

Covid-19 cases expected to rise through August amid heatwave and vacation season: KDCA

Reimbursement for oral Fabry disease drug Galafold expanded to 1st-line treatment

Dental implants lead growth as Korea’s medical device market hits ₩10.5 trillion

As Enhertu expands, AstraZeneca taps Korean startup AIVIS for AI-powered HER2 reads

[Column] Medical device approval: AI could be the answer – with a caveat

From legacy brands to future breakthroughs: how Merck KGaA is redefining its role in oncology

EzDiatech’s blood test for rapid concussion diagnosis lands Korean approval

Konkuk’s blood toxicity-predicting AI wins grand prize at medical data contest

Urinary urgency and pain during intercourse could signal interstitial cystitis